Literature DB >> 6522621

Leukotriene C4 production during hypoxic pulmonary vasoconstriction in isolated rat lungs.

M L Morganroth, K R Stenmark, J A Zirrolli, R Mauldin, M Mathias, J T Reeves, R C Murphy, N F Voelkel.   

Abstract

Leukotriene inhibitors preferentially inhibit hypoxic pulmonary vasoconstriction in isolated rat lungs. If lipoxygenase products are involved in the hypoxic pressor response they might be produced during acute alveolar hypoxia and a leukotriene inhibitor should block both the vasoconstriction and leukotriene production that occurs in response to hypoxia. We investigated in isolated blood perfused rat lungs whether leukotriene C4 (LTC4) could be recovered from whole lung lavage fluid during ongoing hypoxic vasoconstriction. Lung lavage from individual rats had slow reacting substance (SRS)-like myotropic activity by guinea pig ileum bioassay. Pooled lavage (10 lungs) as analyzed by reverse phase high performance liquid chromatography had an ultraviolet absorbing component at the retention time for LTC4. At radioimmunoassay, and SRS myotropic activity by bioassay. LTC4 was not found during normoxic ventilation, during normoxic ventilation after a hypoxic pressor response, or during vasoconstriction elicited by KCl. Diethylcarbamazine citrate, a leukotriene synthesis blocker, concomitantly inhibited the hypoxic vasoconstriction and LTC4 production. Thus 5-lipoxygenase products may play a role in the sequence of events leading to hypoxic pulmonary vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6522621     DOI: 10.1016/0090-6980(84)90040-6

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  10 in total

1.  Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4.

Authors:  P J Piper; A G Stewart
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

Review 2.  Endothelial modification of pulmonary vascular tone.

Authors:  N P Curzen; K B Jourdan; J A Mitchell
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

3.  Sickle erythrocytes and platelets augment lung leukotriene synthesis with downregulation of anti-inflammatory proteins: relevance in the pathology of the acute chest syndrome.

Authors:  Michael Opene; Joseph Kurantsin-Mills; Sumair Husain; Basil O Ibe
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

4.  The role of leukotrienes in acute hypoxic pulmonary vasoconstriction in rats.

Authors:  S R Li; D X Wang
Journal:  J Tongji Med Univ       Date:  1986

Review 5.  Role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in hypoxia-induced pulmonary hypertension.

Authors:  Daling Zhu; Yajuan Ran
Journal:  J Physiol Sci       Date:  2012-02-14       Impact factor: 2.781

6.  Cyclooxygenase-2 inhibition and hypoxia-induced pulmonary hypertension: effects on pulmonary vascular remodeling and contractility.

Authors:  Laura E Fredenburgh; Jun Ma; Mark A Perrella
Journal:  Trends Cardiovasc Med       Date:  2009-02       Impact factor: 6.677

7.  Effects of acute ingestion of ethanol on hemodynamics and hypoxic pulmonary vasoconstriction in dogs--role of leukotrienes.

Authors:  C Y Lu; D X Wang; S B Yu
Journal:  J Tongji Med Univ       Date:  1992

8.  Comparison of regional pulmonary perfusion in lobar pneumonia during high frequency and conventional mechanical ventilation in sheep.

Authors:  M J Girotti; K Hong; W C Demajo; T R Todd
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

Review 9.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

10.  A new treatment for severe pulmonary arterial hypertension based on an old idea: inhibition of 5-lipoxygenase.

Authors:  Norbert F Voelkel; Marc Peters-Golden
Journal:  Pulm Circ       Date:  2020-03-26       Impact factor: 3.017

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.